Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China

Figure 1

The distribution of age at diagnosis of HER2-positive advanced breast cancer in China (a) and the United States (b) (2012–2014).

(a)

(b)